Free Newsletter
Researcher turns to patients for financial support
The Wall Street Journal carries an in-depth feature on the work of James P. Bennett Jr., director of the Center for the Study of Neurodegenerative Diseases at the University of Virginia, who's been turning to trial patients to help pay for his investigation into a new therapy for ALS. With many drug developers uninterested in developing treatments for diseases that afflict only a tiny population, researchers like Bennett have been asking patients to send a check in order to keep the studies going. Bennett has already divested himself of any ownership in the therapy, but the fundraising approach is spurring a discussion in research circles over the relationship between researcher and patient.
- read the article from the Wall Street Journal
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: